CABALETTA BIO INC
CABANASDAQ🏆 #2808 by market capEarnings Nov 5US Equity
$2.83▲ $0.04 (+1.26%)
Live1h▲ 0.5%
24h▲ 1.3%
7d▲ 3.9%
14d▲ 7.8%
30d▲ 2.2%
1y▲ 114.0%
🏦Market Cap
$461M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
56
Weak
📊
Analyst Ratings
Price
$2.83
Total
12
Raised
0
Lowered
1
Avg PT
$16.33
H / L
$32 / $3
| Institution | Action | Rating | Date |
|---|---|---|---|
Wells Fargo | Reiterated | Equal Weight | 2026-05-15 |
Cantor Fitzgerald | Reiterated | Overweight | 2026-05-04 |
Guggenheim | Reiterated | Buy | 2026-03-24 |
Morgan Stanley | Reiterated | Overweight | 2026-03-24 |
HC Wainwright & Co. | Reiterated | Buy | 2025-10-10 |
Citigroup | Reiterated | Buy | 2025-08-14 |
UBS | Reiterated | Buy | 2025-04-01 |
Evercore ISI Group | Downgraded | Outperform → In Line | 2024-12-20 |
Stifel | Reiterated | Buy | 2024-06-17 |
Chardan Capital | Reiterated | Buy | 2023-03-22 |
Mizuho | Reiterated | Buy | 2023-03-17 |
Cowen & Co. | Reiterated | Outperform | 2019-11-19 |
One row per institution, most recent rating